UB faculty members Stelios T. Andreadis and M. Laura Feltri have been elected Fellows of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific association and publisher of the Science family of journals. rice field.
Lifetime honors are awarded to AAAS members by their peers for outstanding efforts, scientifically or socially, to advance scientific applications. The UB faculty and staff is one of more than 500 scientists, engineers and innovators who have received prestigious awards this year. Past winners include WEB DuBois, Ellen Ochoa, Steven Chu, Grace Hopper, Alan Alda, Mae Jemison and Ayanna Howard.
AAAS Fellows will be recognized in February by Science magazine and will be recognized at an induction ceremony this summer.
Stelios Andredis, a SUNY Distinguished Professor of Chemical and Biotechnology and Biomedical Engineering, is an internationally recognized leader in the field of stem cell engineering, especially cardiovascular tissue engineering. His pioneering research has led to engineering tissues for regenerative medicine, including bioengineered arteries and veins, skin, skeletal muscle, and salivary glands. Improved sources of stem cells and novel biomaterials (elastomers, hydrogels) for delivery of cells, genes and proteins for tissue regeneration.
More recently, his research has advanced our understanding of vascular and skeletal muscle aging and how it can be reversed, revealed the role of the immune system in the endothelialization of bioengineered arteries, and demonstrated the ability to replace arteries in patients. The world’s products have been created.
Andreadis co-founded Angiograft LLC to commercialize acellular vascular grafts developed in his laboratory as arterial replacement grafts for the treatment of cardiovascular disease.
He has received over $25 million in research funding from public and private sources, including the National Institutes of Health, the National Science Foundation, NYSTEM, and private foundations. He has published over 140 of his peer-reviewed publications and has given over 90 invited seminars. He has advised 35 doctoral students, 21 master’s students, 7 postdoctoral researchers, and over 50 undergraduate researchers.
Andreadis is Director of the UB Cell, Gene and Tissue Engineering Center and served as Director of the Stem Cells in Regenerative Medicine (SCiRM) training program funded by NYSTEM to train students in Stem Cell Biology and Biotechnology. Stem cells in regenerative medicine. He also served as Chair of the Department of Chemical and Biotechnology from 2012 until 2018.
He has received numerous accolades, including being elected as a Fellow of the Biomedical Engineering Society (BMES), the American Institute of Chemical Engineers (AIChE), and the American Institute of Biomedical Engineering (AIMBE) Fellow College. He received his UB Outstanding Graduate Student Mentoring Award in 2018, his SUNY Presidential Award for Scholarships and Creative Activities in 2014, his NSF His Career Award in 2000, and the Whitaker Foundation Young Investigator in 1999. Awarded.
M. Laura Feltoli, Distinguished Professor of Biochemistry and Neurology at the State University of New York Jacobs School of Medicine and Director of the Myelin and Glia Exploration Laboratory at UB is an internationally renowned expert in the research and development of novel myelin disorders in the nervous system and a pioneer. therapy for them.
With major funding from the National Institutes of Health, Feltri has developed the first mutagenesis tools to study the development of myelin-producing Schwann cells and the signals that regulate myelination. He made many original discoveries in the field. Working with Lawrence Wrabetz, she pioneered the use of transgenic animals to model neurological disorders and develop new treatments.
Feltri’s research focuses on multiple sclerosis (MS). Charcot-Marie-Tooth (CMT) disease, which affects peripheral nerves. and Krabbe leukodystrophy, a rare and fatal neurological disease that afflicts newborns.
Her latest research has allowed us to identify molecular targets that inhibit remyelination in MS and several targets that may ameliorate CMT-hereditary neuropathy. She and her colleagues are partnering with Empire Her Discovery Her Institute and pharmaceutical companies in these efforts.
Feltri is also studying how Krabbe disease develops by developing organoids (“mini-brains” grown in the lab) generated from stem cells of people with and without Krabbe disease. increase. The research is funded by Legacy of Angels, a foundation that supports research in developing and enhancing treatments for Krabbe disease and cystic fibrosis.
Many national and international organizations have turned to Feltri’s expertise. She was a member of the Scientific Advisory Board of the Muscular Dystrophy Association and a member of her Cellular & Molecular Biology in her Glia Study Section of the National Institute of Neurological Disorders and Stroke at NIH.
Early in her career, she won the International Society for Neurochemistry’s Collochia Award for Young Researchers. In 2020, she was an invited speaker at her 2020 Nobel Mini Symposium held at the Karolinska Institutet in Stockholm.
Feltri has advised and mentored numerous undergraduate, master’s and doctoral students at UB and in 2013 was awarded the Distinguished Postdoc Mentor Award by UB’s Office of Postdoctoral Scholars.
Feltri is president-elect of the Peripheral Nerve Society and serves on the editorial boards of various journals and on the boards of several scientific organizations.